Client
Hummsa Biotech
Service
Science Communication | Website Content | Investor Deck
Deliverables
Website | Corporate Pitch Deck | Speech | Design
About the Client
Hummsa Biotech is an oncology- and metabolic-focused biopharmaceutical company pioneering next-generation oral therapeutics. With over two decades of expertise in oncology and translational research, Hummsa is advancing disease-modifying therapies that go beyond symptom control, aiming to restore cellular function and achieve multi-organ benefits.
Challenge
As a young, innovation-driven biopharma company, Hummsa Biotech needed:
A global-facing website that reflected scientific depth while remaining accessible to diverse stakeholders.
A pitch deck that clearly communicated its differentiated pipeline (e.g., oral small-molecule GLP-1s) to investors and collaborators.
Narrative frameworks for leadership to establish thought leadership in international forums.
A design language that balanced credibility, clarity, and visual impact across all assets.
Approach
Hummsa Biotech partnered with SciRio to translate its scientific strengths into compelling narratives across platforms:
Website Development & Content
Created content that distilled complex science (GLP-1 receptor agonists, beta-cell regeneration, multi-organ impact) into accessible, engaging messaging. Inputs on design ensured clarity, clean navigation, and global appeal.
Investor Pitch Deck
Structured and wrote a high-impact deck covering unmet needs, pipeline differentiation (HB-PK002), market opportunity (~$150B GLP-1 market by 2030), licensing interest, and fundraising strategy.
Speech Outline
Developed a keynote-style outline: “Biopharma Innovation Landscape & Next-Gen Therapeutics: The Rise of Oligonucleotides & Aptamers.”
The talk positioned Hummsa as a forward-looking player in programmable therapeutics, highlighting India’s opportunity to lead in scalable precision biotech.
Design Language Inputs
Ensured consistency across web, deck, and speech collaterals—using clean visuals, data-driven storytelling, and simplified iconography to resonate with scientific and business stakeholders alike.
Results
The collaboration delivered:
A professional global website that communicates Hummsa’s scientific innovation and vision with credibility.
An investor-ready deck that supports fundraising and licensing discussions with pharma partners.
A thought leadership framework enabling Hummsa’s leadership to engage in strategic conversations about next-gen therapeutics.
A cohesive brand voice across all digital and offline communication assets, strengthening Hummsa’s positioning as an emerging biopharma innovator.
This project highlights how SciRio empowers emerging biotech companies like Hummsa Biotech to bridge the gap between cutting-edge research and global stakeholder communication.
HAPPY CLIENTS
